JPS56123911A - Nonoral administration solvent and manufacture stable solution containing solvent - Google Patents

Nonoral administration solvent and manufacture stable solution containing solvent

Info

Publication number
JPS56123911A
JPS56123911A JP15235880A JP15235880A JPS56123911A JP S56123911 A JPS56123911 A JP S56123911A JP 15235880 A JP15235880 A JP 15235880A JP 15235880 A JP15235880 A JP 15235880A JP S56123911 A JPS56123911 A JP S56123911A
Authority
JP
Japan
Prior art keywords
solvent
solution containing
stable solution
manufacture stable
nonoral administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP15235880A
Other languages
English (en)
Japanese (ja)
Inventor
Tokachiei Nojiyu Gueizo
Sepeshi Gabooru
Gozudogu Mario
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Publication of JPS56123911A publication Critical patent/JPS56123911A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP15235880A 1979-11-02 1980-10-31 Nonoral administration solvent and manufacture stable solution containing solvent Pending JPS56123911A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79RI733A HU181940B (en) 1979-11-02 1979-11-02 Process for producing solutions of vincane derivatives for parentheral application

Publications (1)

Publication Number Publication Date
JPS56123911A true JPS56123911A (en) 1981-09-29

Family

ID=11001115

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15235880A Pending JPS56123911A (en) 1979-11-02 1980-10-31 Nonoral administration solvent and manufacture stable solution containing solvent

Country Status (24)

Country Link
US (1) US4344950A (OSRAM)
JP (1) JPS56123911A (OSRAM)
AR (1) AR223735A1 (OSRAM)
AT (1) AT377914B (OSRAM)
AU (1) AU533715B2 (OSRAM)
BE (1) BE885987A (OSRAM)
CA (1) CA1159367A (OSRAM)
CH (1) CH645019A5 (OSRAM)
CS (1) CS226417B2 (OSRAM)
DD (1) DD153760A5 (OSRAM)
DE (1) DE3041368A1 (OSRAM)
DK (1) DK464680A (OSRAM)
FI (1) FI803401L (OSRAM)
FR (1) FR2468373A1 (OSRAM)
GB (1) GB2062464B (OSRAM)
HU (1) HU181940B (OSRAM)
IL (1) IL61310A (OSRAM)
IT (1) IT1209367B (OSRAM)
NL (1) NL8005980A (OSRAM)
NO (1) NO803254L (OSRAM)
PH (1) PH17037A (OSRAM)
SE (1) SE8007569L (OSRAM)
YU (1) YU278880A (OSRAM)
ZA (1) ZA806468B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170152B (it) * 1982-07-19 1987-06-03 Lilly Co Eli Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi
US4619935A (en) * 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
US5360593A (en) * 1987-12-29 1994-11-01 Alcon Laboratories, Inc. Heat sterilization of labile antibiotics
CN101721361B (zh) * 2009-12-08 2013-06-26 李荣立 长春胺注射剂及其制备工艺
CN112649522B (zh) * 2020-11-30 2022-02-22 海南葫芦娃药业集团股份有限公司 一种注射液中有关物质长春胺酸与阿朴长春胺酸的检测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3005754A (en) * 1957-08-16 1961-10-24 Bristol Myers Co Tetracycline formulations
US3155586A (en) * 1963-01-23 1964-11-03 American Cyanamid Co Stable liquid preparations of 6-demethyltetracyclines
US3159542A (en) * 1962-12-31 1964-12-01 American Cyanamid Co Stable aqueous glycol solution of tetracycline aluminum calcium gluconate complex having a ph of about 7. 5 to 9
GB1005342A (en) * 1963-01-23 1965-09-22 Olin Mathieson Pharmaceutical preparations containing choline ester salts
FR2191891B1 (OSRAM) * 1972-07-13 1975-08-08 Roussel Uclaf
FR2279394A2 (fr) * 1973-12-13 1976-02-20 Saunier Laboratoires Medicament pour le traitement des insuffisances circulatoires cerebrales

Also Published As

Publication number Publication date
CS226417B2 (en) 1984-03-19
IL61310A0 (en) 1980-12-31
GB2062464A (en) 1981-05-28
FR2468373A1 (fr) 1981-05-08
DK464680A (da) 1981-05-03
ZA806468B (en) 1981-10-28
BE885987A (fr) 1981-02-16
FI803401A7 (fi) 1981-05-03
IT8025683A0 (it) 1980-10-31
CH645019A5 (de) 1984-09-14
SE8007569L (sv) 1981-05-03
HU181940B (en) 1983-11-28
IL61310A (en) 1984-08-31
DD153760A5 (de) 1982-02-03
FI803401L (fi) 1981-05-03
PH17037A (en) 1984-05-17
US4344950A (en) 1982-08-17
YU278880A (en) 1984-04-30
AR223735A1 (es) 1981-09-15
FR2468373B1 (OSRAM) 1984-12-28
AT377914B (de) 1985-05-28
GB2062464B (en) 1983-12-07
CA1159367A (en) 1983-12-27
NL8005980A (nl) 1981-06-01
NO803254L (no) 1981-05-04
ATA527980A (de) 1984-10-15
DE3041368A1 (de) 1981-05-14
AU6400480A (en) 1981-05-07
IT1209367B (it) 1989-07-16
AU533715B2 (en) 1983-12-08

Similar Documents

Publication Publication Date Title
JPS5318557A (en) Novel aminoalkylfuran derivatives* their preparation and medical composition containing same
ZA771998B (en) Triazolo-pyrimidines and pharmaceutical compositions containing them
JPS5379020A (en) Isosorbido containing medicine
NZ185356A (en) 1-aryloxy-2-hydroxy-3-alkyleneaminopropanes and pharmaceutical compositions containing them
NZ179733A (en) Stable insulin preparation
JPS557272A (en) Drug composition containing urea
JPS5297921A (en) Aralkylaniline derivative* preparation thereof and medical composition containing same
JPS5340765A (en) Novel indole derivative* its preparation and medicine containing same
JPS5350161A (en) Pyrazolee11yllphenylacetic acid*its preparation and agent containing same
JPS5315367A (en) 22benzilpyrrolidine* preparation thereof and medicine containing same
DE2960024D1 (en) Substituted diphenylmethyl-imidazoles, their preparation and medicaments containing them
JPS53124238A (en) New prostan derivative * preparation thereof and medicine containing same
JPS54157817A (en) Pharmaceutical prepared solution
JPS55392A (en) Muramyllpeptide type novel compounds and drug containing them
JPS5522692A (en) Stable liquid drug composition and its manufacture
JPS52102279A (en) And its preparation and medical composition containing same
JPS56123911A (en) Nonoral administration solvent and manufacture stable solution containing solvent
JPS5416482A (en) Novel benzylpyrimidine*its preparation and medicine containing same
JPS52128364A (en) Novel corticoid * preparation thereof and antiiinflamatory pharmaceutical agent containing the same
JPS54130586A (en) 55fluorouracil derivative*its manufacture and drug containing it
IL53026A0 (en) New pyridobenzodiazepinones their preparation and pharmaceutical compositions containing them
AU535357B2 (en) Stable pharmaceutical solution
JPS54151992A (en) Alkoxycarbonyll33benzodiazepin novel derivatives*their manufacture and medicine containing them
JPS52136181A (en) Novel 55phenylcarbamoyllbarbituric acid and insecticides containing same and their usage
JPS5419986A (en) Novel amidinoobenzylpyrimidine*its preparation and medicine containing same